Last reviewed · How we verify
Indomethacin Capsules low dose
At a glance
| Generic name | Indomethacin Capsules low dose |
|---|---|
| Sponsor | Iroko Pharmaceuticals, LLC |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Study of Indomethacin Capsules to Treat Pain Following Surgery in Children Ages 6 to <17 Years of Age (PHASE2)
- Effect of Meloxicam Tablets on Bleeding Time in Healthy Subjects (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Indomethacin Capsules low dose CI brief — competitive landscape report
- Indomethacin Capsules low dose updates RSS · CI watch RSS
- Iroko Pharmaceuticals, LLC portfolio CI